Aida Pharmaceuticals Stock Performance
| AIDA Stock | USD 0.0002 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Aida Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Aida Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental indicators, Aida Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
Aida |
Aida Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 0.02 in Aida Pharmaceuticals on September 27, 2025 and sell it today you would earn a total of 0.00 from holding Aida Pharmaceuticals or generate 0.0% return on investment over 90 days. Aida Pharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Aida, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Aida Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aida Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Aida Pharmaceuticals, and traders can use it to determine the average amount a Aida Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| AIDA |
Based on monthly moving average Aida Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aida Pharmaceuticals by adding Aida Pharmaceuticals to a well-diversified portfolio.
Aida Pharmaceuticals Fundamentals Growth
Aida Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Aida Pharmaceuticals, and Aida Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aida Pink Sheet performance.
| Return On Equity | -0.0179 | |||
| Return On Asset | 0.0662 | |||
| Profit Margin | (0.05) % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 8.37 M | |||
| Price To Earning | (0.25) X | |||
| Price To Book | 0.77 X | |||
| Price To Sales | 0.21 X | |||
| Revenue | 29.2 M | |||
| EBITDA | 9.51 M | |||
| Cash And Equivalents | 8.28 M | |||
| Cash Per Share | 0.31 X | |||
| Debt To Equity | 2.37 % | |||
| Book Value Per Share | 0.34 X | |||
| Cash Flow From Operations | 8.39 M | |||
| Earnings Per Share | (0.08) X | |||
| Total Asset | 62.73 M | |||
| Retained Earnings | 2.75 M | |||
| Current Asset | 32.28 M | |||
| Current Liabilities | 44.37 M | |||
About Aida Pharmaceuticals Performance
By analyzing Aida Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Aida Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Aida Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aida Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China. Aida Pharmaceuticals is traded on OTC Exchange in the United States.Things to note about Aida Pharmaceuticals performance evaluation
Checking the ongoing alerts about Aida Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Aida Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aida Pharmaceuticals generated a negative expected return over the last 90 days | |
| Aida Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Aida Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company has a current ratio of 0.72, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Aida Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Aida Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aida Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aida to invest in growth at high rates of return. When we think about Aida Pharmaceuticals' use of debt, we should always consider it together with cash and equity. |
- Analyzing Aida Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aida Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Aida Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aida Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aida Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aida Pharmaceuticals' pink sheet. These opinions can provide insight into Aida Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Aida Pink Sheet analysis
When running Aida Pharmaceuticals' price analysis, check to measure Aida Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aida Pharmaceuticals is operating at the current time. Most of Aida Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aida Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aida Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aida Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |